http://www.drugs.com/pro/paragard.html
Vaginal bleeding
In the 2 largest clinical trials with ParaGard ® (see ADVERSE REACTIONS: menstrual changes were the most common medical reason for discontinuation of ParaGard ®. Discontinuation rates for pain and bleeding combined are highest in the first year of use and diminish thereafter. The percentage of women who discontinued ParaGard ® because of bleeding problems or pain during these studies ranged from 11.9% in the first year to 2.2 % in year 9. Women complaining of heavy vaginal bleeding should be evaluated and treated, and may need to discontinue ParaGard ®.
The following adverse events have also been observed. These are listed alphabetically and not by order of frequency or severity.
Anemia
Menstrual flow, prolonged
Backache
Menstrual spotting
Dysmenorrhea
Pain and cramping
Dyspereunia
Urticarial allergic skin reaction
Expulsion, complete or partial
Vaginitis
Leukorrhea